Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation

Expanded partnership with academic and public US and French institutions, with University of Vermont Health Network and ARIS (Agence Régionale Investissements Stratégiques) now among our shareholders, to enhance our innovation…

Continue ReadingCilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation